SeaStar Medical Holding (ICU) EBITDA Margin (2024 - 2026)
SeaStar Medical Holding's (ICU) quarterly EBITDA Margin came in at 720.6% in Q1 2026, up 55340.0% YoY from N/an in Q1 2025, and little changed on a QoQ basis from 718.1% in Q4 2025.
SeaStar Medical Holding (ICU) EBITDA Margin (2024 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 3 years of EBITDA Margin data on file, last reported at 720.6% in Q1 2026.
- Quarterly EBITDA Margin rose 55340.0% year-over-year to 720.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 829.56% (up 324262.0% YoY) and the FY2025 annual result came in at 986.63%, up 1222967.0% from the prior year.
- EBITDA Margin steadied at 720.6% in Q1 2026, from 718.1% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 519.53% in Q2 2025 to a low of 7114.93% in Q4 2024.
- A 3-year average of 2693.69% and a median of 1274.0% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2025 — EBITDA Margin soared 639683 bps — and 2026, when it surged 55340 bps.
- Tracing ICU's EBITDA Margin over 3 years: stood at 7114.93% in 2024, then surged by 90 bps to 718.1% in 2025, then retreated by 0 bps to 720.6% in 2026.
- The last three EBITDA Margin figures came in at 720.6% (Q1 2026), 718.1% (Q4 2025), and 1955.74% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.75% |
| 10 | SeaStar Medical Holding | 14.00 Mn | 7.00 Mn | 561,000.00 | -616.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -616.42% |
| Mar 31, 2026 | -720.60% |
| Dec 31, 2025 | -718.10% |
| Sep 30, 2025 | -1,955.74% |
| Jun 30, 2025 | -519.53% |
| Mar 31, 2025 | -1,274.00% |
| Dec 31, 2024 | -7,114.93% |
| Sep 30, 2024 | -6,552.94% |